Newsroom

Sorted by: Latest

-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Silverstone Master Issuer Plc   GBP 600,000,000.00   MATURING: 21-Jan-2070   ISIN: XS2716761668     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Apr-2026 TO 21-Jul-2026 HAS BEEN FIXED AT 4.25 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 21-Jul-2026 WILL AMOUNT TO: GBP 10.59 PER GBP 1,000.00 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: HOPS HILL NO 5   GBP 7,600,000.00   MATURING: 21-Jun-2056   ISIN: XS3102045872     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Jun-2026 TO 21-Jul-2026 HAS BEEN FIXED AT 5.44 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 21-Jul-2026 WILL AMOUNT TO: GBP 34,546.83 PER GBP 8,000,000.00 DENOMINATION  ...
-

ERM FUNDING PLC. UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: ERM FUNDING PLC.   GBP 100.00   MATURING: 31-Dec-2099   ISIN: XS2351471060     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 15-Apr-2026 TO 15-Jul-2026 HAS BEEN FIXED AT 0.00 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 15-Jul-2026 WILL AMOUNT TO: GBP .0 PER GBP 100.00 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Silverstone Master Issuer Plc   GBP 500,000,000.00   MATURING: 21-Jan-2070   ISIN: XS2716762393     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Apr-2026 TO 21-Jul-2026 HAS BEEN FIXED AT 4.25 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 21-Jul-2026 WILL AMOUNT TO: GBP 10.59 PER GBP 1,000.00 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Silverstone Master Issuer Plc   GBP 750,000,000.00   MATURING: 23-Jan-2079   ISIN: XS3301049451     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Apr-2026 TO 21-Jul-2026 HAS BEEN FIXED AT 4.31 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 21-Jul-2026 WILL AMOUNT TO: GBP 10.74 PER GBP 1,000.00 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Hops Hill NO 4PLC   GBP 475,000,000.00   MATURING: 21-Apr-2056   ISIN: XS2802115167     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Jun-2026 TO 21-Jul-2026 HAS BEEN FIXED AT 4.62 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 21-Jul-2026 WILL AMOUNT TO: GBP 1,075,145.16 PER GBP 293,206,955.90 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: HOPS HILL NO 5   GBP 6,764,000.00   MATURING: 21-Jun-2056   ISIN: XS3102046094     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Jun-2026 TO 21-Jul-2026 HAS BEEN FIXED AT 7.24 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 21-Jul-2026 WILL AMOUNT TO: GBP 40,929.26 PER GBP 7,120,000.00 DENOMINATION  ...
-

Redwood Logistics Cut Cost Per Click by Nearly 99% with ZoomInfo

VANCOUVER, Wash.--(BUSINESS WIRE)--ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, has reported that Redwood Logistics, a leader in modern supply chain solutions, has cut its cost per click by nearly 99%, to as low as $1.20, using ZoomInfo, according to the company. Redwood knows optimization. It moves freight at scale, and it realized its own go-to-market operations needed the same treatment. When a new senior director of digital strategy took over Redwood's go-to-market technology, th...
-

Incyte présente les données de phase 1/2 sur les doses multiples du VGA039 (latarcibart) lors du congrès de l’ISTH 2026, montrant une réduction significative des hémorragies chez les patients atteints de tous les types de maladie de von Willebrand

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq : INCY) a annoncé aujourd’hui la publication des données complètes de sécurité et d’efficacité concernant l’ensemble des patients (n = 16) inclus dans l’étude de phase 1/2 à doses multiples sur le VGA039 (latarcibart), un nouvel anticorps monoclonal expérimental ciblant la protéine S, destiné aux patients atteints de la maladie de von Willebrand (VWD). Ces données sont présentées aujourd’hui lors d’une communication orale au 34e congrès de l...